Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Audrey Duquette"'
Autor:
Aly-Khan A. Lalani, Wanling Xie, Dylan J. Martini, John A. Steinharter, Craig K. Norton, Katherine M. Krajewski, Audrey Duquette, Dominick Bossé, Joaquim Bellmunt, Eliezer M. Van Allen, Bradley A. McGregor, Chad J. Creighton, Lauren C. Harshman, Toni K. Choueiri
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-9 (2018)
Abstract Background An elevated Neutrophil-to-lymphocyte ratio (NLR) is associated with worse outcomes in several malignancies. However, its role with contemporary immune checkpoint blockade (ICB) is unknown. We investigated the utility of NLR in met
Externí odkaz:
https://doaj.org/article/a6286eee898049b499b9ec3627a32985
Autor:
Audrey Duquette, Vincent A. Miller, Aly-Khan A. Lalani, Toni K. Choueiri, Siraj M. Ali, A. Ari Hakimi, Stephanie A. Wankowicz, Lauren Young, Jeffrey S. Ross, Sabina Signoretti, Sumanta K. Pal, Russell Madison, Dominick Bossé, Guillermo de Velasco, Philip J. Stephens, Craig Norton
Publikováno v:
British Journal of Cancer
Background The genomic landscape of primary clear cell renal cell carcinoma (ccRCC) has been well described. However, little is known about cohort genomic alterations (GA) landscape in ccRCC metastases, or how it compares to primary tumours in aggreg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a60d378dba0ec43a4b39c0a234c5454f
http://europepmc.org/articles/PMC5943584
http://europepmc.org/articles/PMC5943584
Autor:
Lauren C. Harshman, Craig Norton, Dylan J. Martini, Audrey Duquette, Aly-Khan A. Lalani, John A. Steinharter, Katherine M. Krajewski, Dominick Bossé, Wanling Xie, Joaquim Bellmunt, Chad J. Creighton, Bradley Alexander McGregor, Eliezer M. Van Allen, Toni K. Choueiri
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-9 (2018)
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-9 (2018)
Background An elevated Neutrophil-to-lymphocyte ratio (NLR) is associated with worse outcomes in several malignancies. However, its role with contemporary immune checkpoint blockade (ICB) is unknown. We investigated the utility of NLR in metastatic r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0216ce21acb44eec35faf6fe705da0ac
https://doi.org/10.1186/s40425-018-0315-0
https://doi.org/10.1186/s40425-018-0315-0
Autor:
James Brugarolas, Aly-Khan A. Lalani, Sun Young Rha, Wanling Xie, Camillo Porta, Georg A. Bjarnason, Dominick Bossé, Audrey Duquette, Benoit Beuselinck, M. Neil Reaume, Lori Wood, A. Ari Hakimi, Frede Donskov, Sandy Srinivas, Naveen S. Basappa, Brian I. Rini, Aaron R. Hansen, Renzo G. DiNatale, Toni K. Choueiri, Daniel Y.C. Heng
Publikováno v:
Journal of Clinical Oncology. 36:667-667
667 Background: Recent research suggested that patients (pts) with small renal masses (4cm or less) were at low risk of disease recurrence after surgery. The impact of tumor size on survival in mRCC patients treated with targeted therapy (TKI) is unc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43f79f62fd2708c5ed5a8791f8a80d9f
https://doi.org/10.1200/jco.2018.36.6_suppl.667
https://doi.org/10.1200/jco.2018.36.6_suppl.667